重组人p16-INK4a-TAT

重组人p16-INK4a-TAT

收藏
  • ¥1838
  • peprotech
  • USA
  • 110-02T
  • 2025年12月08日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 英文名

      Cyclin-dependent kinase inhibitor 2A, Cyclin-dependent kinase 4 inhibitor A, CDK4I, p16INK4A, p16-INK4, Multiple tumor suppressor 1, MTS-1

    • 供应商

      研卉生物

    • 规格

      25ug

    重组人p16-INK4a-TAT(Recombinant Human p16-INK4a-TAT)
    别名:Cyclin-dependent kinase inhibitor 2A,
    Cyclin-dependent kinase 4 inhibitor A,
    CDK4I,
    p16INK4A,
    p16-INK4,
    Multiple tumor suppressor 1,
    MTS-1
    Description:
    p16-INK4a is a nuclear protein that regulates the cell cycle by inhibiting cyclin-dependent kinase-4 (CDK4) and CDK6. p16-INK4a inhibits CDK activity by binding to the CDK molecules in a manner that interferes with their ability to interact with cyclin D. This activity has the effect of suppressing tumor formation and growth, and of inducing replicative senescence in various normal cells, including stem cells. The expression of p16-INK4a steadily increases with age, and tends to accumulate in stem cell compartments. The deletion, rearrangement, or mutation of the p16-INK4a gene is frequently found in melanomas, as well as in certain other types of cancer. p16-INK4a and other transcription factors have been introduced into cells by DNA transfection, viral infection, or microinjection. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors and other nuclear proteins into primary, as well as transformed, cells. Recombinant Human p16-INK4a-TAT expressed in E. coli is an 18.0 kDa protein containing 167 amino-acid residues, including the 155 residues of full-length p16-INK4a and a 12-residue C-terminal TAT peptide (GYGRKKRRQRRR).
    AA Sequence:
    EPAAGSSMEP SADWLATAAA RGRVEEVRAL LEAGALPNAP NSYGRRPIQV MMMGSARVAE LLLLHGAEPN CADPATLTRP VHDAAREGFL DTLVVLHRAG ARLDVRDAWG RLPVDLAEEL GHRDVARYLR AAAGGTRGSN HARIDAAEGP SDIPDGYGRK KRRQRRR
    Source:
    E.coli
    Purity:
    Greater than 95% by SDS-PAGE gel and HPLC analyses.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2580
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2025年08月12日询价
    ¥2600
    上海研卉生物科技有限公司
    2025年10月18日询价
    询价
    武汉禾元生物科技股份有限公司
    2025年12月08日询价
    ¥2405
    北京百普赛斯生物科技股份有限公司
    2025年10月26日询价
    询价
    北京博生福生物技术有限责任公司
    2025年12月09日询价
    重组人p16-INK4a-TAT
    ¥1838